ReP USP - Resultado da busca

Artigo de periodico
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families (2014)
Cury, Nathalia Moreno; Ferraz, Victor Evangelista de Faria; Silva Júnior, Wilson Araújo da
Source: Hereditary Cancer in Clinical Practice. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS (GENÉTICA), HEREDITARIEDADE, ESTUDOS DE CASOS E CONTROLES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CURY, Nathalia Moreno e FERRAZ, Victor Evangelista de Faria e SILVA JÚNIOR, Wilson Araújo da. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary Cancer in Clinical Practice, v. 12, 2014Tradução . . Disponível em: https://doi.org/10.1186/1897-4287-12-8. Acesso em: 04 nov. 2025.
APA
Cury, N. M., Ferraz, V. E. de F., & Silva Júnior, W. A. da. (2014). TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families. Hereditary Cancer in Clinical Practice, 12. doi:10.1186/1897-4287-12-8
NLM
Cury NM, Ferraz VE de F, Silva Júnior WA da. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families [Internet]. Hereditary Cancer in Clinical Practice. 2014 ; 12[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-12-8
Vancouver
Cury NM, Ferraz VE de F, Silva Júnior WA da. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families [Internet]. Hereditary Cancer in Clinical Practice. 2014 ; 12[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-12-8
Artigo de periodico
Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors? (2013)
Guindalini, Rodrigo Santa Cruz; Oliveira, Edite Paulo de; Silvino, Marina Cavalcanto Moroja; Hoff, Paulo Marcelo; Garicochea , Bernardo
Source: Hereditary Cancer in Clinical Practice. Unidade: FM
Subjects: GENÉTICA MÉDICA, FATORES DE RISCO, BIÓPSIA, DOENÇAS HEREDITÁRIAS, NEOPLASIAS TESTICULARES (CIRURGIA), TESTÍCULO (ULTRASONOGRAFIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUINDALINI, Rodrigo Santa Cruz et al. Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?. Hereditary Cancer in Clinical Practice, v. 11, n. 1, p. (online), 2013Tradução . . Disponível em: https://doi.org/10.1186/1897-4287-11-1. Acesso em: 04 nov. 2025.
APA
Guindalini, R. S. C., Oliveira, E. P. de, Silvino, M. C. M., Hoff, P. M., & Garicochea , B. (2013). Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors? Hereditary Cancer in Clinical Practice, 11( 1), (online). doi:10.1186/1897-4287-11-1
NLM
Guindalini RSC, Oliveira EP de, Silvino MCM, Hoff PM, Garicochea B. Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors? [Internet]. Hereditary Cancer in Clinical Practice. 2013 ; 11( 1): (online).[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-11-1
Vancouver
Guindalini RSC, Oliveira EP de, Silvino MCM, Hoff PM, Garicochea B. Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors? [Internet]. Hereditary Cancer in Clinical Practice. 2013 ; 11( 1): (online).[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-11-1
Artigo de periodico
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome (2011)
Ewald, Ingrid P.; Izetti, Patrícia; Vargas, Fernando R.; Moreira, Miguel A. M.; Moreira, Aline S.; Moreira-Filho, Carlos A.; Cunha, Danielle R.; Hamaguchi, Sara; Camey, Suzi A.; Schmidt, Aishameriane; Caleffi, Maira; Koehler-Santos, Patrícia; Giugliani, Roberto; Ashton-Prolla, Patricia
Source: Hereditary Cancer in Clinical Practice. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (GENÉTICA), FATORES DE RISCO, GENES (ANÁLISE), DOENÇAS HEREDITÁRIAS, NEOPLASIAS OVARIANAS (GENÉTICA), MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EWALD, Ingrid P. et al. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, v. 9, n. 1, p. (online), 2011Tradução . . Disponível em: https://doi.org/10.1186/1897-4287-9-12. Acesso em: 04 nov. 2025.
APA
Ewald, I. P., Izetti, P., Vargas, F. R., Moreira, M. A. M., Moreira, A. S., Moreira-Filho, C. A., et al. (2011). Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, 9( 1), (online). doi:10.1186/1897-4287-9-12
NLM
Ewald IP, Izetti P, Vargas FR, Moreira MAM, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome [Internet]. Hereditary Cancer in Clinical Practice. 2011 ; 9( 1): (online).[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-9-12
Vancouver
Ewald IP, Izetti P, Vargas FR, Moreira MAM, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome [Internet]. Hereditary Cancer in Clinical Practice. 2011 ; 9( 1): (online).[citado 2025 nov. 04 ] Available from: https://doi.org/10.1186/1897-4287-9-12

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em